If you got diabetes while using statins like Lipitor to treat your cholesterol, you may be eligible to compensation by filing a Lipitor Lawsuit against the manufacturer, Pfizer.
If you or a loved one has been diagnosed with diabetes as a result of taking Lipitor, our Houston Lipitor lawyers will gladly analyze your dangerous drug claim with a free, no-obligation evaluation to see if you qualify for the Lipitor Diabetes Lawsuit.
Lipitor, manufactured by Pfizer, is the most-prescribed medicine in history but several studies now indicate that it is linked to an increased risk of diabetes.
Individuals have developed type-2 diabetes after starting Lipitor medication, while leading healthy and active lifestyles. Individuals with type-2 diabetes must undergo regular blood glucose testing, follow a diabetic diet, and take diabetes medication as a result of their diagnosis. Diabetes patients are also at a higher risk of heart disease, blindness, neuropathy, and renal damage.
We believe that despite Pfizer knowing of the Lipitor diabetes risk, Pfizer promoted and marketed Lipitor as safe and effective which resulted in many injured individuals.
Companies that prioritize money before safety should be held accountable for their conduct. We are offering a free, no-obligation evaluation of your medical history for possible inclusion in the Lipitor diabetes litigation at Ramji Law Group. Our Houston attorneys will tell you straight up whether or not you should join the Lipitor lawsuit.
A number of studies have linked statins including Lipitor (atorvastatin), Crestor (rosuvastatin), as well as Zocor (simvastatin, produced by Merck) to an increased risk of diabetes. In fact, a Lipitor FDA diabetes warning was required to be included on the Lipitor label following a safety announcement on February 28, 2012 that warned of the Lipitor diabetes risk as well as other Lipitor side effects.
A study published in BMJ on May 23, 2013 confirmed the Lipitor FDA diabetes warning and earlier research when it concluded that statins, such as Lipitor, had a higher incident of diabetes risk than pravastatin. The study analyzed patients in Ontario, Canada treated with Lipitor, Crestor and Zocor. The team of researchers examined the healthcare records of more than 1.5 million patients aged 66 or older without diabetes who started statin treatment between August 1997 and March 2010. Overall, a 10-22% increased risk of diabetes was found.
The BMJ study follows a Women’s Health Initiative study published on January 23, 2012, which found a nearly 50% increase in new onset diabetes for postmenopausal women with statins compared with a placebo.
In addition to the risk of diabetes, a BMJ research paper published on March 19, 2013 noted that users of “high potency statins” (including Lipitor) were 34% more likely to be hospitalized with acute kidney injury within 120 days after starting treatment, again confirming the need for the Lipitor FDA diabetes warning.
Contact a Houston Lipitor lawyer to discuss your case.
We’re here to help. Schedule a freeevaluation with an experienced personal injury lawyer in Houston, TX today by filling out the form below, or call us at (713) 888-8888